Advanced gastric adenocarcinoma
Clinical trials for Advanced gastric adenocarcinoma explained in plain language.
Never miss a new study
Get alerted when new Advanced gastric adenocarcinoma trials appear
Sign up with your email to follow new studies for Advanced gastric adenocarcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Triple drug cocktail targets tough stomach cancer
Disease control CompletedThis phase 2 study is testing a combination of three drugs—paclitaxel (a chemotherapy), pembrolizumab (an immunotherapy), and olaparib (a targeted therapy)—in 36 adults with advanced gastric or gastroesophageal cancer that has worsened after one prior treatment. The goal is to se…
Matched conditions: ADVANCED GASTRIC ADENOCARCINOMA
Phase 2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
New combo shows promise for stomach cancer patients with hidden HER2 signal
Disease control CompletedThis phase II study tested whether adding trastuzumab (a targeted therapy) to standard chemotherapy could help people with advanced stomach or gastroesophageal junction cancer. Unlike typical patients, these participants had tumors that tested negative for HER2 in tissue but posi…
Matched conditions: ADVANCED GASTRIC ADENOCARCINOMA
Phase 2 • Sponsor: Asan Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug cocktail shows promise for tough stomach cancer
Disease control CompletedThis study tested whether adding fruquintinib to standard chemotherapy (paclitaxel) helps people with advanced stomach cancer live longer. It included 703 patients whose cancer had worsened after initial treatment. The goal was to see if the combination improves survival and slow…
Matched conditions: ADVANCED GASTRIC ADENOCARCINOMA
Phase 3 • Sponsor: Hutchison Medipharma Limited • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC